Search For "clinical trials"
Bharat Biotech gets SEC approval for phase 3 clinical trials of COVID boos
Updated : 4 years, 2 months ago IST
New Delhi [India], January 5 (ANI): The Subject Experts Committee (SEC) of the Drug Controller General of India (DCGI) on Wednesday granted approval to Bharat Biotech for conducting intranasal phase 3 trials and heterologous trials for COVID-19 booster intranasal vaccine for those who hav
Read More
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 stud
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 2 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
No recommendations for COVID-19 booster dose by SEC: Sources
Updated : 4 years, 3 months ago IST
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
Read More
Antibody measurement promises smaller, quicker clinical vaccine trials: US
Updated : 4 years, 3 months ago IST
Washington [US], December 8 (ANI/Sputnik): Antibody measurements shortly after people were vaccinated against COVID-19 revealed the potential for speedier clinical trials of new vaccine candidates with fewer participants, the National Institutes of Health (NIH) said.
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 3 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
The Whiteboard announces partnership with Oviya MedSafe for pharmacovigila
Updated : 4 years, 5 months ago IST
Hyderabad (Telangana) [India], October 11 (ANI/NewsVoir): The Whiteboard, a leading academy for training professionals in the field of clinical trials and drug development, announced on Oct 6th, 2021, a partnership with Oviya MedSafe, a global pharmacovigilance consulting and drug safety ser
Read More
Covid antiviral pill cuts risk of hospitalisation, deaths by half, says ma
Updated : 4 years, 5 months ago IST
Washington [US], October 1 (ANI): An antiviral pill has been found to reduce the risk of hospitalisation and deaths by 50 per cent in patients diagnosed with COVID-19 during clinical trials.
Read More
LTI and eClinicalHealth form strategic partnership to accelerate innovatio
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 28 (ANI/PRNewswire): Larsen & Toubro Infotech (BSE: 540005) (NSE: LTI), a global technology consulting and digital solutions company has entered in a strategic partnership with eClinicalHealth Limited to accelerate digital innovation in R&D Cli
Read More
India tops the chart for approved biosimilars and clinical trials surpassi
Updated : 4 years, 5 months ago IST
Bengaluru (Karnataka) [India], September 24 (ANI/PRNewswire): With an overarching theme of 'Ideate and Innovate' and new prospects of Intellectual Property (IP) in the Indian pharmaceutical industry, Informa Pharma Intelligence, the Knowledge Partner of Pharma IPR 2021, has today concluded t
Read More